Li Hui, Bui Bang V, Cull Grant, Wang Fang, Wang Lin
Department of Ophthalmology, The Tenth People's Hospital, Shanghai, Tongji University School of Medicine, Shanghai, China 2Devers Eye Institute, Legacy Research Institute, Portland, Oregon, USA.
Department of Optometry and Vision Sciences, University of Melbourne, Parkville, Victoria, Australia.
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):1-8. doi: 10.1167/iovs.16-20804.
The purpose of this study was to test the hypothesis that retinal glial cells modify basal vessel diameter and pressure-initiated vascular regulation in rat retina.
In rats, L-2-aminoadipic acid (LAA, 10 nM) was intravitreally injected to inhibit glial cell activity. Twenty-four hours following injection, retinal glial intracellular calcium (Ca2+) was labeled with the fluorescent calcium indicator Fluo-4/AM (F4, 1 mM). At 110 minutes after injection, intraocular pressure (IOP) was elevated from 20 to 50 mm Hg. Prior to and during IOP elevation, Ca2+ and retinal vessel diameter were assessed using a spectral-domain optical coherence tomography/confocal scanning laser ophthalmoscope. Dynamic changes in Ca2+ and diameter from IOP elevation were quantified. The response in LAA-treated eyes was compared with vehicle treated control eyes.
L-2-Aminoadipic acid treatment significantly reduced F4-positive cells in the retina (LAA, 16 ± 20 vs. control, 55 ± 37 cells/mm2; P = 0.02). Twenty-four hours following LAA treatment, basal venous diameter was increased from 38.9 ± 3.9 to 51.8 ± 6.4 μm (P < 0.0001, n = 20), whereas arterial diameter was unchanged (from 30.3 ± 3.5 to 30.7 ± 2.8 μm; P = 0.64). In response to IOP elevation, LAA-treated eyes showed a smaller increase in glial cell Ca2+ around both arteries and veins in comparison with control (P < 0.001 for both). There was also significantly greater IOP-induced vasoconstriction in both vessel types (P = 0.05 and P = 0.02, respectively; n = 6 each).
The results suggest that glial cells can modulate basal retinal venous diameter and contribute to pressure-initiated vascular responses.
本研究旨在验证视网膜神经胶质细胞可调节大鼠视网膜基底血管直径及压力引发的血管调节这一假说。
给大鼠玻璃体内注射L-2-氨基己二酸(LAA,10 nM)以抑制神经胶质细胞活性。注射24小时后,用荧光钙指示剂Fluo-4/AM(F4,1 mM)标记视网膜神经胶质细胞内钙(Ca2+)。注射110分钟后,将眼压从20 mmHg升高至50 mmHg。在眼压升高之前及过程中,使用光谱域光学相干断层扫描/共焦扫描激光检眼镜评估Ca2+和视网膜血管直径。对眼压升高引起的Ca2+和直径的动态变化进行量化。将LAA处理组的眼睛与溶剂处理的对照组眼睛的反应进行比较。
L-2-氨基己二酸处理显著减少了视网膜中F4阳性细胞(LAA组为16±20个细胞/mm2,对照组为55±37个细胞/mm2;P = 0.02)。LAA处理24小时后,基底静脉直径从38.9±3.9μm增加到51.8±6.4μm(P < 0.0001,n = 20),而动脉直径未改变(从30.3±3.5μm到30.7±2.8μm;P = 0.64)。与对照组相比,在眼压升高时,LAA处理组的眼睛在动脉和静脉周围神经胶质细胞Ca2+的增加较小(两者P < 0.001)。两种血管类型中眼压诱导的血管收缩也明显更大(分别为P = 0.05和P = 0.02;每组n = 6)。
结果表明神经胶质细胞可调节视网膜基底静脉直径,并参与压力引发的血管反应。